Breaking News Instant updates and real-time market news.

CVAC

CureVac

$14.21 /

+0.5 (+3.65%)

, BNTX

BioNTech

$157.48 /

+8.545 (+5.74%)

07:20
07/05/22
07/05
07:20
07/05/22
07:20

CureVac files patent infringement suit in Germany against BioNTech

CureVac N.V. (CVAC) announced that it has moved to assert its intellectual property rights, accumulated over more than two decades of pioneering work in mRNA technology, which contributed to COVID-19 vaccine development. CureVac has filed a lawsuit in the German Regional Court in Dusseldorf against BioNTech (BNTX) and two of its subsidiaries, seeking fair compensation for infringement of a portfolio of CureVac's intellectual property rights, EP 1 857 122 B1, DE 20 2015 009 961 U1, DE 20 2021 003 575 U1 and DE 20 2015 009 974 U1, utilized in the manufacture and sale of Comirnaty, BioNTech and Pfizer's (PFE) mRNA COVID-19 vaccine. CureVac does not seek an injunction nor intend to take legal action that impedes the production, sale or distribution of Comirnaty by BioNTech and its partner Pfizer. The company said, "The CureVac intellectual property portfolio protects multiple inventions that are considered essential to the design and development of BioNTech's SARS CoV-2 mRNA vaccine, among others. These relate to the engineering of mRNA molecules, including sequence modifications to increase stability and enhance protein expression, as well as mRNA vaccine formulations specific to SARS CoV-2 vaccines. Over the last 22 years, CureVac developed proprietary foundational technology related to mRNA design, delivery and manufacturing that materially contributed to the development of safe and efficacious COVID-19 vaccines. CureVac considers the rapid development of these vaccines a tremendous achievement, with unprecedented positive impact for global public health. This achievement is based on decades of scientific research and innovation, supported by CureVac as the earliest pioneer in mRNA technology. Accordingly, CureVac's intellectual property rights need to be acknowledged and respected in the form of a fair compensation to reinvest into the further advancement of mRNA technology and the ongoing development of new classes of life saving medicines."

CVAC

CureVac

$14.21 /

+0.5 (+3.65%)

BNTX

BioNTech

$157.48 /

+8.545 (+5.74%)

PFE

Pfizer

$52.33 /

-0.18 (-0.34%)

  • 14

    Jul

  • 14

    Jul

  • 28

    Jul

  • 06

    Aug

  • 08

    Aug

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
PNC Bank eliminates non-sufficient fund fees for consumer banking customers » 10:57
08/11/22
08/11
10:57
08/11/22
10:57
PNC

PNC Financial

$171.67 /

+2.49 (+1.47%)

PNC Bank announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNC PNC Financial
$171.67 /

+2.49 (+1.47%)

PNC PNC Financial
$171.67 /

+2.49 (+1.47%)

07/18/22 Morgan Stanley
PNC Financial price target raised to $180 from $168 at Morgan Stanley
07/17/22 Barclays
PNC Financial price target lowered to $222 from $250 at Barclays
07/12/22 Citi
PNC Financial price target lowered to $170 from $190 at Citi
07/12/22 Citi
Citi places 'negative catalyst watches' on KeyCorp, PNC
PNC PNC Financial
$171.67 /

+2.49 (+1.47%)

PNC PNC Financial
$171.67 /

+2.49 (+1.47%)

PNC PNC Financial
$171.67 /

+2.49 (+1.47%)

PNC PNC Financial
$171.67 /

+2.49 (+1.47%)

General news
European Fixed Income Summary: » 10:55
08/11/22
08/11
10:55
08/11/22
10:55
$ECON

Economic Data

/

+

European Fixed Income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
JPMorgan chemicals analyst to hold analyst/industry conference call » 10:54
08/11/22
08/11
10:54
08/11/22
10:54

High Yield Chemicals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Treasure Global opens at $6.69, IPO priced at $4.00 per share » 10:46
08/11/22
08/11
10:46
08/11/22
10:46
TGL

Treasure Global

/

+

Treasure Global (TGL)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 12
    Aug
  • 14
    Jul
Options
Paramount Global call volume above normal and directionally bullish » 10:45
08/11/22
08/11
10:45
08/11/22
10:45
PARA

Paramount

$26.42 /

+1.35 (+5.38%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PARA Paramount
$26.42 /

+1.35 (+5.38%)

PARA Paramount
$26.42 /

+1.35 (+5.38%)

08/05/22 Deutsche Bank
Paramount price target lowered to $32 from $35 at Deutsche Bank
08/05/22 JPMorgan
JPMorgan downgrades Paramount to Underweight on soft DTC revenue
08/05/22 Morgan Stanley
Paramount price target lowered to $20 from $22 at Morgan Stanley
08/05/22 JPMorgan
Paramount downgraded to Underweight from Neutral at JPMorgan
PARA Paramount
$26.42 /

+1.35 (+5.38%)

PARA Paramount
$26.42 /

+1.35 (+5.38%)

PARA Paramount
$26.42 /

+1.35 (+5.38%)

PARA Paramount
$26.42 /

+1.35 (+5.38%)

Conference/Events
Jefferies tech/software analysts to hold an analyst/industry conference call » 10:45
08/11/22
08/11
10:45
08/11/22
10:45
WDAY

Workday

$171.76 /

+0.59 (+0.34%)

Technology/Software…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDAY Workday
$171.76 /

+0.59 (+0.34%)

WDAY Workday
$171.76 /

+0.59 (+0.34%)

07/18/22 Piper Sandler
Workday price target lowered to $175 from $230 at Piper Sandler
06/02/22 Loop Capital
Salesforce price target lowered to $175 from $225 at Loop Capital
05/27/22 DA Davidson
Workday price target lowered to $220 from $250 at DA Davidson
05/27/22 Stifel
Workday price target lowered to $220 from $275 at Stifel
WDAY Workday
$171.76 /

+0.59 (+0.34%)

WDAY Workday
$171.76 /

+0.59 (+0.34%)

WDAY Workday
$171.76 /

+0.59 (+0.34%)

WDAY Workday
$171.76 /

+0.59 (+0.34%)

Conference/Events
JPMorgan medical supplies/devices analyst holds analyst/industry conference call » 10:45
08/11/22
08/11
10:45
08/11/22
10:45

Medical Supplies &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
JPMorgan oil/gas E&P and OFS analyst to hold analyst/industry conference call » 10:40
08/11/22
08/11
10:40
08/11/22
10:40

Oil & Gas E&P and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Week of 8/5 EIA natural gas report 44bcf  10:32
08/11/22
08/11
10:32
08/11/22
10:32
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
BioLargo secures PFAS mitigation customer, signs channel partner » 10:32
08/11/22
08/11
10:32
08/11/22
10:32
BLGO

BioLargo

/

+

BioLargo announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLGO BioLargo
/

+

BLGO BioLargo
/

+

Hot Stocks
Greenwich LifeSciences commences Phase III clincial trial of GLSI-100 » 10:31
08/11/22
08/11
10:31
08/11/22
10:31
GLSI

Greenwich LifeSciences

$10.10 /

+0.28 (+2.85%)

Greenwich LifeSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLSI Greenwich LifeSciences
$10.10 /

+0.28 (+2.85%)

GLSI Greenwich LifeSciences
$10.10 /

+0.28 (+2.85%)

07/12/22 H.C. Wainwright
H.C. Wainwright reiterates $78 target on Greenwich after clinical hold lift
09/01/21 H.C. Wainwright
Greenwich LifeSciences initiated with a Buy at H.C. Wainwright
General news
EIA natural gas storage change for week ending August 5 » 10:31
08/11/22
08/11
10:31
08/11/22
10:31
USO

United States Oil Fund

$75.43 /

+1.09 (+1.47%)

Gas inventories were…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USO United States Oil Fund
$75.43 /

+1.09 (+1.47%)

USO United States Oil Fund
$75.43 /

+1.09 (+1.47%)

USO United States Oil Fund
$75.43 /

+1.09 (+1.47%)

USO United States Oil Fund
$75.43 /

+1.09 (+1.47%)

Options
Carvana call volume above normal and directionally bullish » 10:25
08/11/22
08/11
10:25
08/11/22
10:25
CVNA

Carvana

$55.14 /

+7.91 (+16.75%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$55.14 /

+7.91 (+16.75%)

CVNA Carvana
$55.14 /

+7.91 (+16.75%)

08/08/22 Deutsche Bank
Carvana price target lowered to $42 from $54 at Deutsche Bank
08/08/22 DA Davidson
Carvana price target lowered to $42 from $49 at DA Davidson
08/08/22 JPMorgan
Carvana downgraded to Underweight from Neutral at JPMorgan
08/05/22 BofA
Carvana liquidity concerns easing as margins improve, says BofA
CVNA Carvana
$55.14 /

+7.91 (+16.75%)

  • 22
    Apr
CVNA Carvana
$55.14 /

+7.91 (+16.75%)

CVNA Carvana
$55.14 /

+7.91 (+16.75%)

CVNA Carvana
$55.14 /

+7.91 (+16.75%)

Hot Stocks
XPeng reveals interior and major features of upcoming G9 SUV » 10:23
08/11/22
08/11
10:23
08/11/22
10:23
XPEV

XPeng

$25.47 /

+2.58 (+11.27%)

XPeng announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$25.47 /

+2.58 (+11.27%)

XPEV XPeng
$25.47 /

+2.58 (+11.27%)

08/03/22 Macquarie
XPeng downgraded to Neutral from Outperform at Macquarie
08/01/22 Morgan Stanley
XPeng July deliveries drop 'well expected,' says Morgan Stanley
07/01/22 Nomura
XPeng downgraded to Neutral on short-term cash burn at Nomura
06/30/22 Nomura
XPeng downgraded to Neutral from Buy at Nomura
XPEV XPeng
$25.47 /

+2.58 (+11.27%)

XPEV XPeng
$25.47 /

+2.58 (+11.27%)

XPEV XPeng
$25.47 /

+2.58 (+11.27%)

XPEV XPeng
$25.47 /

+2.58 (+11.27%)

Hot Stocks
Pacific Biosciences trading resumes  10:21
08/11/22
08/11
10:21
08/11/22
10:21
PACB

Pacific Biosciences

$8.63 /

+0.93 (+12.09%)

 
ShowHide Related Items >><<
PACB Pacific Biosciences
$8.63 /

+0.93 (+12.09%)

PACB Pacific Biosciences
$8.63 /

+0.93 (+12.09%)

08/04/22 Canaccord
Pacific Biosciences price target lowered to $14 from $17 at Canaccord
05/15/22 Piper Sandler
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler
05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
PACB Pacific Biosciences
$8.63 /

+0.93 (+12.09%)

PACB Pacific Biosciences
$8.63 /

+0.93 (+12.09%)

PACB Pacific Biosciences
$8.63 /

+0.93 (+12.09%)

Hot Stocks
Hyperfine slides after lowering expectations, Wells Fargo downgrade » 10:19
08/11/22
08/11
10:19
08/11/22
10:19
HYPR

Hyperfine

$1.57 /

-0.305 (-16.27%)

Shares of Hyperfine…

Shares of Hyperfine (HYPR) are under pressure on Thursday as Wells Fargo analyst Larry Biegelsen downgraded the stock to Equal Weight following weaker than expected quarterly results and lowered guidance. The analyst noted that the miss and guidance cut are "even more disappointing" since Hyperfine had reiterated its full year outlook just six weeks ago. RESULTS: Hyperfine reported second quarter losses per share of (33c) and revenue of $1.53M, both below consensus of (27c) and $2M, respectively. The company also said that it now expects revenue for the full year to be between $7M-$8M, down from the previous from $10M-$12M. "We are revising our 2022 expectations to 35 to 45 commercial system installations and $7 million to $8 million in total revenue. Despite our lower near-term expectations, we remain highly confident in our value proposition and long-term goals," Scott Huennekens, Interim President and Chief Executive Officer of Hyperfine, said during the company's earnings conference call. MOVING TO THE SIDELINES: Following the quarterly results, Wells Fargo analyst Larry Biegelsen downgraded Hyperfine to Equal Weight from Overweight with a price target of $2.40, down from $8. The analyst noted the company reported revenue 23% below expectations and lowered its full-year guidance by 32% at the midpoint. The miss and lowered guidance are "even more disappointing" given it comes just six weeks after the company reiterated full-year guidance, Biegelsen added. PRICE ACTION: In Thursday morning trading, shares of Hyperfine have dropped 38c, or 20% to $1.48.

ShowHide Related Items >><<
HYPR Hyperfine
$1.57 /

-0.305 (-16.27%)

HYPR Hyperfine
$1.57 /

-0.305 (-16.27%)

06:35 Today Wells Fargo
Wells Fargo downgrades Hyperfine to Equal Weight, lowers price target to $2.40
05:42 Today Wells Fargo
Hyperfine downgraded to Equal Weight from Overweight at Wells Fargo
05/31/22 Evercore ISI
Hyperfine initiated with an Outperform at Evercore ISI
04/14/22 Wells Fargo
Hyperfine initiated with an Overweight at Wells Fargo
HYPR Hyperfine
$1.57 /

-0.305 (-16.27%)

HYPR Hyperfine
$1.57 /

-0.305 (-16.27%)

Hot Stocks
Pacific Biosciences trading halted, volatility trading pause  10:17
08/11/22
08/11
10:17
08/11/22
10:17
PACB

Pacific Biosciences

$8.33 /

+0.635 (+8.25%)

 
ShowHide Related Items >><<
PACB Pacific Biosciences
$8.33 /

+0.635 (+8.25%)

PACB Pacific Biosciences
$8.33 /

+0.635 (+8.25%)

08/04/22 Canaccord
Pacific Biosciences price target lowered to $14 from $17 at Canaccord
05/15/22 Piper Sandler
Pacific Biosciences price target lowered to $6 from $13 at Piper Sandler
05/05/22 Cantor Fitzgerald
Pacific Biosciences price target lowered to $19 from $23 at Cantor Fitzgerald
03/01/22 Piper Sandler
Pacific Biosciences price target lowered to $13 from $20 at Piper Sandler
PACB Pacific Biosciences
$8.33 /

+0.635 (+8.25%)

PACB Pacific Biosciences
$8.33 /

+0.635 (+8.25%)

PACB Pacific Biosciences
$8.33 /

+0.635 (+8.25%)

Technical Analysis
NASDAQ market internals summary » 10:17
08/11/22
08/11
10:17
08/11/22
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 10:16
08/11/22
08/11
10:16
08/11/22
10:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
PLBY Group put volume heavy and directionally bearish » 10:15
08/11/22
08/11
10:15
08/11/22
10:15
PLBY

PLBY Group

$6.11 /

+0.33 (+5.71%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLBY PLBY Group
$6.11 /

+0.33 (+5.71%)

PLBY PLBY Group
$6.11 /

+0.33 (+5.71%)

08/10/22 Canaccord
PLBY Group price target lowered to $14 from $18 at Canaccord
07/20/22 Stifel
Stifel downgrades trio of Sports and Lifestyle Brands to Hold
07/20/22 Stifel
PLBY Group downgraded to Hold from Buy at Stifel
05/16/22 Loop Capital
PLBY Group price target lowered to $13 from $26 at Loop Capital
PLBY PLBY Group
$6.11 /

+0.33 (+5.71%)

PLBY PLBY Group
$6.11 /

+0.33 (+5.71%)

PLBY PLBY Group
$6.11 /

+0.33 (+5.71%)

Conference/Events
JPMorgan business/info services analyst holds analyst/industry conference call » 10:15
08/11/22
08/11
10:15
08/11/22
10:15

Business &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Lithium Corp., Morella enter formal agreement for North Big Smoky » 10:12
08/11/22
08/11
10:12
08/11/22
10:12
LTUM

Lithium Corp.

/

+

Lithium Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LTUM Lithium Corp.
/

+

LTUM Lithium Corp.
/

+

Hot Stocks
Paige enters partnership with Sonora Quest Laboratories » 10:10
08/11/22
08/11
10:10
08/11/22
10:10
DGX

Quest Diagnostics

$142.15 /

+1.36 (+0.97%)

Paige announced it will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DGX Quest Diagnostics
$142.15 /

+1.36 (+0.97%)

DGX Quest Diagnostics
$142.15 /

+1.36 (+0.97%)

07/22/22 Mizuho
Quest Diagnostics price target lowered to $160 from $185 at Mizuho
07/22/22 Credit Suisse
Quest Diagnostics price target lowered to $143 from $158 at Credit Suisse
04/24/22 UBS
Quest Diagnostics price target raised to $150 from $139 at UBS
04/04/22 Citi
Quest Diagnostics downgraded on post-COVID uncertainty at Citi
DGX Quest Diagnostics
$142.15 /

+1.36 (+0.97%)

DGX Quest Diagnostics
$142.15 /

+1.36 (+0.97%)

Conference/Events
Bernstein analysts to hold an analyst/industry conference call » 10:09
08/11/22
08/11
10:09
08/11/22
10:09

Analysts Larson and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Fiverr partners with Selina to bring together 'Anywhere Workers' » 10:09
08/11/22
08/11
10:09
08/11/22
10:09
FVRR

Fiverr

$45.00 /

+3.17 (+7.58%)

, BOAS

BOA Acquisition

$9.84 /

+ (+0.00%)

Fiverr International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$45.00 /

+3.17 (+7.58%)

BOAS BOA Acquisition
$9.84 /

+ (+0.00%)

FVRR Fiverr
$45.00 /

+3.17 (+7.58%)

08/05/22 Needham
Fiverr price target raised to $50 from $40 at Needham
08/04/22 Piper Sandler
Piper Sandler applauds strategic pivot at Fiverr, keeps $50 target
07/26/22 Piper Sandler
Fiverr layoffs point to focus on profitability, says Piper Sandler
05/16/22 Stifel
Upwork downgraded to Hold from Buy at Stifel
BOAS BOA Acquisition
$9.84 /

+ (+0.00%)

FVRR Fiverr
$45.00 /

+3.17 (+7.58%)

FVRR Fiverr
$45.00 /

+3.17 (+7.58%)

FVRR Fiverr
$45.00 /

+3.17 (+7.58%)

FVRR Fiverr
$45.00 /

+3.17 (+7.58%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.